Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives.

Cells
Mirella PastoreChiara Raggi

Abstract

Cholangiocarcinoma (CCA) is a deadly tumor without an effective therapy. Unique metabolic and bioenergetics features are important hallmarks of tumor cells. Metabolic plasticity allows cancer cells to survive in poor nutrient environments and maximize cell growth by sustaining survival, proliferation, and metastasis. In recent years, an increasing number of studies have shown that specific signaling networks contribute to malignant tumor onset by reprogramming metabolic traits. Several evidences demonstrate that numerous metabolic mediators represent key-players of CCA progression by regulating many signaling pathways. Besides the well-known Warburg effect, several other different pathways involving carbohydrates, proteins, lipids, and nucleic acids metabolism are altered in CCA. The goal of this review is to highlight the main metabolic processes involved in the cholangio-carcinogeneis that might be considered as potential novel druggable candidates for this disease.

References

Nov 14, 1985·The New England Journal of Medicine·C NiederauG Strohmeyer
Sep 27, 2000·International Journal of Cancer. Journal International Du Cancer·J V SwinnenG Verhoeven
May 19, 2001·Journal of Gastroenterology and Hepatology·A E SiricaZ Zhang
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N HayashiM Monden
Jun 1, 2002·Science·Lewis C Cantley
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kanenori EndoAlphonse E Sirica
Oct 3, 2002·Seminars in Liver Disease·Alphonse E SiricaByung-Il Yoon
Jul 1, 1959·Cancer·P E STEINER, J HIGGINSON
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zichen ZhangAlphonse E Sirica
May 5, 2004·Journal of Hepatology·Yasser H ShaibHashem B El-Serag
Jun 1, 2005·Biochimica Et Biophysica Acta·Tong Wu
Dec 1, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hajime IsomotoGregory J Gores
May 27, 2006·Science·Ken Garber
Jun 13, 2006·Cancer Cell·Thi Bui, Craig B Thompson
Oct 19, 2006·Current Opinion in Cell Biology·Reuben J Shaw
Dec 16, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Sadahiro AmemoriKazuma Fujimoto
Apr 28, 2007·World Journal of Gastroenterology : WJG·Kawin LeelawatSuradej Hongeng
Sep 21, 2007·Nature Reviews. Cancer·Javier A Menendez, Ruth Lupu
Dec 1, 2007·Endocrine Reviews·Vincent Poitout, R Paul Robertson
Jan 25, 2008·Nature Reviews. Molecular Cell Biology·Matthias P Wymann, Roger Schneiter
Mar 1, 2008·International Journal of Clinical Oncology·Magnus RizellPer Lindnér
Aug 12, 2008·Current Drug Targets·Dai ShidaSarah Spiegel
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joon-Yong ChungStephen M Hewitt
Jun 17, 2009·Molecular and Cellular Biology·Erinn B RankinVolker H Haase
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Oct 7, 2009·The Journal of Physiology·George A Brooks
Nov 26, 2009·Nature·Lenny DangShinsan M Su
Dec 22, 2009·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Domenico AlvaroUNKNOWN AISF Cholangiocarcinoma committee
Jan 12, 2010·The Journal of Pharmacology and Experimental Therapeutics·Kevin J FrenchCharles D Smith
Jan 13, 2010·World Journal of Gastroenterology : WJG·Samuel WolfMarcus Wiedmann
Feb 4, 2010·Acta Neuropathologica·Fonnet E BleekerCornelis J F Van Noorden
Aug 24, 2010·World Journal of Gastroenterology : WJG·Warapen Treekitkarnmongkol, Tuangporn Suthiphongchai
Dec 31, 2010·World Journal of Hepatology·Yasuni NakanumaHiroko Ikeda
Apr 12, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michelle L DeoliveiraPierre-Alain Clavien
Sep 24, 2011·Hepato-gastroenterology·Yuji MorineHidenori Miyake

❮ Previous
Next ❯

Citations

May 31, 2021·Journal of Hepato-biliary-pancreatic Sciences·Soravis OsataphanCharupong Saengboonmee
Oct 31, 2020·Cancer Letters·Jian YangHanxiang Zhan

❮ Previous
Next ❯

Methods Mentioned

BETA
environmental stress
nuclear translocation
acetylation
xenograft
genotyping

Clinical Trials Mentioned

NCT02989857
NCT02273739

Software Mentioned

CCA

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Related Papers

Expert Opinion on Therapeutic Targets
Keisaku SatoGianfranco Alpini
World Journal of Gastrointestinal Oncology
Hamzeh KayhanianChiara Braconi
Visceral Medicine
Martha M Kirstein, Arndt Vogel
© 2021 Meta ULC. All rights reserved